Call Hammers Car Accident & Personal Injury Lawyers for a free case evaluation from an Atlanta Ozempic, Wegovy, and Mounjaro lawyer.
Most recently, GLP-1 receptor agonists have dominated headlines for their dual benefits in glycemic control and weight reduction, but the broader market is undergoing significant shifts
Filingeri noted that this research study was designed to further examine changes in weight, body fat mass, and muscle mass in patients taking incretin medications. We found that, under close supervision and regular follow-up from an obesity medicine specialist, patients were able to lose fat mass with only a minimal decline in muscle mass. Alexandra Filingeri, DCN, RCN Filingeri pointed out that the results of this study cannot be generalized to patients receiving medication via telemedicine without routine body composition analysis, nor can they be generalized to in-person visits without utilizing body composition analysis
HiGoodHealth.com and its contributors do not endorse, recommend, or promote any specific drug, brand, pharmaceutical company, or treatment
